Diamyd Medical AB - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Diamyd Medical AB. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Diamyd Medical AB. The Group's primary activity is the development of medicine for diabetes. The Group operates in two segments: GAD technology and NTDDS technology. The GAD technology segment comprises of GAD-protein and Diamyd anti-GAD RIA-kits. The products are sold to researchers and laboratories. The NTDDS segment include the Group's first drug candidate from theNerve Targeting Drug Delivery System (NTDDS) gene therapy platform. The Group operates globally.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report